Africa is grappling with a worsening mpox crisis, with a critical shortfall of vaccine doses threatening to derail ...

German science and technology firm Merck KGaA (MRK: DE) has moved a step closer to introducing a new therapy for tenosynovial ...

Following global reports of serious adverse events in older people, the government’s independent expert advisory body, the UK ...

US ophthalmic gene therapy company Beacon Therapeutics, which is focused on restoring the vision of patients with blinding ...

UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease ...

Shares in US pharma giant Merck & Co (NYSE: MRK) were nearly 2% higher in early trading Monday.

Shares of Avidity Biosciences (Nasdaq: RNA) were up almost 5% at $38.00 pre-market today, as it announced the accelerated ...

Swiss skincare specialist Galderma has announced two-year data from a new interim analysis of a long-term extension study ...

South Korea’s biosimilar drug developer Samsung Bioepis has announced that the company has entered into a license, ...

George Medicines, a late-stage UK-based biopharmaceutical company focused on addressing unmet needs in cardiometabolic ...

Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...

As Denmark presses ahead with a major health reform, a coalition of rare disease advocates and clinicians is urging the ...